SCHEMBL30423637

SCHEMBL30423637

Nc1nc(O[C@H]2COC[C@H]2F)cc(N2CCC3(CCCC(=O)N3c3ccc(F)c(F)c3)CC2)n1

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TPH1 P17752 3/20 0.33
EP300 Q09472 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24253857 1.00 TPH1 (0.33) TPH1EP300
SCHEMBL30424565 1.00 TPH1 (0.33) TPH1EP300
SCHEMBL24253750 1.00 TPH1 (0.33) TPH1EP300
SCHEMBL30494535 0.93 TPH1 (0.32) TPH1EP300
SCHEMBL24253559 0.93 TPH1 (0.32) TPH1EP300
SCHEMBL24253867 0.88
SCHEMBL30423918 0.88 EP300 (0.30) EP300
SCHEMBL24253860 0.88 EP300 (0.30) EP300
SCHEMBL24253864 0.86
SCHEMBL30424524 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4196478-A1 HETEROARYL SUBSTITUTED SPIROPIPERIDINYL DERIVATIVES AND PHARMACEUTICAL USES THEREOF Novartis AG (CH) 2023-06-21 EP claimed
CN-116157404-A Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof 诺华股份有限公司 2023-05-23 CN claimed
EP-4196478-A1 HETEROARYL SUBSTITUTED SPIROPIPERIDINYL DERIVATIVES AND PHARMACEUTICAL USES THEREOF Novartis AG (CH) 2023-06-21 EP disclosed
CN-116157404-A Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof 诺华股份有限公司 2023-05-23 CN disclosed